Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles

Tadanori Yamada, Masakazu Ueda, Masaharu Seno, Akihiko Kondo, Katsuyuki Tanizawa, Shun'ichi Kuroda

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The hepatitis B virus (HBV) surface antigen (HBsAg) L particle is a hollow nano-scale particle. HBsAg L particles have many properties that make them useful for in vivo gene transfer vectors and drug delivery systems. Gene therapy so far has required the in vivo pinpoint delivery of genetic materials into the target organs and cells. Gene transfer by HBsAg L particles might be an attractive method, since their tropism is the same as that of HBV. The HBsAg L particles are able to deliver therapeutic payloads with high specificity to human hepatocytes. In addition, the specificity of L particle can be altered by displaying various cell-binding molecules on the surface. Our results indicate that the L particle is suitable for a cell- and tissue-specific gene/drug transfer vector. In this review, we discuss HBsAg L particles as a gene/drug transfer vector and its potential for the treatment of infectious diseases.

Original languageEnglish
Pages (from-to)163-167
Number of pages5
JournalCurrent Drug Targets - Infectious Disorders
Volume4
Issue number2
DOIs
Publication statusPublished - 2004

Fingerprint

Gene Transfer Techniques
Drug Delivery Systems
Hepatitis B virus
Virion
Surface Antigens
Genes
Tropism
Hepatitis B Surface Antigens
Pharmaceutical Preparations
Genetic Therapy
Communicable Diseases
Hepatocytes
antigen L
Therapeutics

Keywords

  • Drug system
  • Gene delivery
  • HBsAg L particle
  • in vivo system

ASJC Scopus subject areas

  • Molecular Medicine
  • Microbiology (medical)
  • Pharmacology

Cite this

Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles. / Yamada, Tadanori; Ueda, Masakazu; Seno, Masaharu; Kondo, Akihiko; Tanizawa, Katsuyuki; Kuroda, Shun'ichi.

In: Current Drug Targets - Infectious Disorders, Vol. 4, No. 2, 2004, p. 163-167.

Research output: Contribution to journalArticle

Yamada, Tadanori ; Ueda, Masakazu ; Seno, Masaharu ; Kondo, Akihiko ; Tanizawa, Katsuyuki ; Kuroda, Shun'ichi. / Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles. In: Current Drug Targets - Infectious Disorders. 2004 ; Vol. 4, No. 2. pp. 163-167.
@article{8f724fa3db604a65bb4bb8936033134a,
title = "Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles",
abstract = "The hepatitis B virus (HBV) surface antigen (HBsAg) L particle is a hollow nano-scale particle. HBsAg L particles have many properties that make them useful for in vivo gene transfer vectors and drug delivery systems. Gene therapy so far has required the in vivo pinpoint delivery of genetic materials into the target organs and cells. Gene transfer by HBsAg L particles might be an attractive method, since their tropism is the same as that of HBV. The HBsAg L particles are able to deliver therapeutic payloads with high specificity to human hepatocytes. In addition, the specificity of L particle can be altered by displaying various cell-binding molecules on the surface. Our results indicate that the L particle is suitable for a cell- and tissue-specific gene/drug transfer vector. In this review, we discuss HBsAg L particles as a gene/drug transfer vector and its potential for the treatment of infectious diseases.",
keywords = "Drug system, Gene delivery, HBsAg L particle, in vivo system",
author = "Tadanori Yamada and Masakazu Ueda and Masaharu Seno and Akihiko Kondo and Katsuyuki Tanizawa and Shun'ichi Kuroda",
year = "2004",
doi = "10.2174/1568005043341037",
language = "English",
volume = "4",
pages = "163--167",
journal = "Infectious Disorders - Drug Targets",
issn = "1871-5265",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Novel tissue and cell type-specific gene/drug delivery system using surface engineered hepatitis B virus nano-particles

AU - Yamada, Tadanori

AU - Ueda, Masakazu

AU - Seno, Masaharu

AU - Kondo, Akihiko

AU - Tanizawa, Katsuyuki

AU - Kuroda, Shun'ichi

PY - 2004

Y1 - 2004

N2 - The hepatitis B virus (HBV) surface antigen (HBsAg) L particle is a hollow nano-scale particle. HBsAg L particles have many properties that make them useful for in vivo gene transfer vectors and drug delivery systems. Gene therapy so far has required the in vivo pinpoint delivery of genetic materials into the target organs and cells. Gene transfer by HBsAg L particles might be an attractive method, since their tropism is the same as that of HBV. The HBsAg L particles are able to deliver therapeutic payloads with high specificity to human hepatocytes. In addition, the specificity of L particle can be altered by displaying various cell-binding molecules on the surface. Our results indicate that the L particle is suitable for a cell- and tissue-specific gene/drug transfer vector. In this review, we discuss HBsAg L particles as a gene/drug transfer vector and its potential for the treatment of infectious diseases.

AB - The hepatitis B virus (HBV) surface antigen (HBsAg) L particle is a hollow nano-scale particle. HBsAg L particles have many properties that make them useful for in vivo gene transfer vectors and drug delivery systems. Gene therapy so far has required the in vivo pinpoint delivery of genetic materials into the target organs and cells. Gene transfer by HBsAg L particles might be an attractive method, since their tropism is the same as that of HBV. The HBsAg L particles are able to deliver therapeutic payloads with high specificity to human hepatocytes. In addition, the specificity of L particle can be altered by displaying various cell-binding molecules on the surface. Our results indicate that the L particle is suitable for a cell- and tissue-specific gene/drug transfer vector. In this review, we discuss HBsAg L particles as a gene/drug transfer vector and its potential for the treatment of infectious diseases.

KW - Drug system

KW - Gene delivery

KW - HBsAg L particle

KW - in vivo system

UR - http://www.scopus.com/inward/record.url?scp=2942740807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942740807&partnerID=8YFLogxK

U2 - 10.2174/1568005043341037

DO - 10.2174/1568005043341037

M3 - Article

C2 - 15180463

AN - SCOPUS:2942740807

VL - 4

SP - 163

EP - 167

JO - Infectious Disorders - Drug Targets

JF - Infectious Disorders - Drug Targets

SN - 1871-5265

IS - 2

ER -